Millennium Settles False Claims Case, Still Faces Another
This article was originally published in The Gray Sheet
Executive Summary
A diagnostic company agreed to pay $256 million to settle False Claims Act allegations this week, but further payouts may be on the horizon due to a newly unsealed case alleging unnecessary pharmacogenetic testing.